Log In
BCIQ
Print this Print this
 

Acurita (STP601)

  Manage Alerts
Collapse Summary General Information
Company Sirnaomics Inc.
DescriptionIntravitreous short interfering RNA (siRNA) nanoparticle solution targeting VEGF
Molecular Target Vascular endothelial growth factor (VEGF) receptor 1 (FLT1) (VEGFR-1) ; Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)
Mechanism of Action 
Therapeutic ModalityNucleic acid: Linear RNA: siRNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$9.7M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/23/2011

$9.7M

Undisclosed

Undisclosed

Get a free BioCentury trial today